Saints Capital — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Ceroracerora.comin𝕏Mar 2016
Cerora develops biosensor-based neurodiagnostic technology to provide objective, portable data for assessing brain function, with an initial focus on concussion and mild traumatic brain injury.
Digital HealthHealthtechMedical DevicesBethlehem, US
Adam Simon(CEO)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Direct Flow MedicalSiftery
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

